US$ 26.45
novo nordisk is cutting prices on its popular glp-1 drugs. cuts 70%, but semaglutide revenue could grow in 2026 Novo Nordisk cuts prices as
Description
New Engl J Med

Retrieved from Wharton-b, S., Blevins, T., Connery, L., et al

Estimated Sustainable Cost-based Prices for Diabetes Medicines

Diabetes Obes Metab 23(9):21162124
